What Life Sciences Hub Wales does

Life Sciences Hub Wales Ltd (Company No. 08719645) is a private company limited by guarantee and an Arms-Length Body of the Welsh Government, wholly owned by the Welsh Ministers and headquartered at 3 Assembly Square, Cardiff Bay. Founded in 2014 with 53 employees, the organisation serves as a connector, facilitator and driver for life sciences and health innovation in Wales, operating exclusively within a single-country domestic remit. Its offering is a portfolio of advisory, funding-navigation, and coordination services organised around five core pillars — Economic Development Support, Funding Support, Sector Intelligence, Programme Delivery, and Partnerships — supplemented by structured sub-products (Business Case Development, Project Management Support, an Innovation Enquiry Form intake, a Funding Directory, an Innovation Directory, Training & Development resources, Sector Intelligence Reports, and the Hub Highlights Newsletter) and coordinated flagship programmes including the Tackling Cancer Programme, the All-Wales Robotic Assisted Surgery Programme, the QuicDNA liquid biopsy programme, the Innovation in Women's Cancer Accelerator Fund, the Health+ Programme, and the Cross-Sector Programme with the Academy of Medical Sciences.

The underlying technology stack consists of standard enterprise software — Microsoft 365, Mailchimp, Eventbrite, Zoom, Cloudbooking, Xero, Syft, ApprovalMax, and a CRM — with no proprietary software products or AI platforms developed in-house. The portfolio does, however, surface third-party AI innovations across the ecosystem, including a multimodal AI/MRI prostate cancer diagnostic aid, the RiTTA oncology virtual assistant (built with Velindre, Pfizer Oncology, and IBM Watson), generative AI tools for research analysis, and the Electronic Prescription Service as a process automation exemplar. Strategic technology partners include Digital Health and Care Wales, with integrations limited to Google Analytics and Google AdWords for marketing.

Life Sciences Hub Wales operates on a government-funding model with no commercial revenue streams and provides all services free of charge to eligible innovators, NHS organisations, and industry partners. There is no publicly disclosed pricing; the revenue model is categorised in the input data as licensing/royalties only by default, but in practice all operating income derives from Welsh Government grant funding under ministerial mandate, with major programmes (Tackling Cancer, QuicDNA expansion, robotic surgery) funded by specific Welsh Government allocations and Innovate UK co-funding routed through the Hub. The customer base spans three primary segments — Industry (200+ life sciences companies served), Health and Social Care Organisations (all NHS Wales health boards, trusts, local authorities, and social care providers), and Academia (Welsh universities including Swansea University) — with cancer care innovation treated as a cross-cutting use case (19,500 annual diagnoses, 2,300 lung cancer cases per year). Distribution is exclusively direct through field advisors and enquiry-led engagement; the Hub does not sell products through third-party channels.

Name

Life Sciences Hub Wales

Legal name

Life Sciences Hub Wales Ltd

Website

https://lshubwales.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Life Sciences Hub Wales is a Welsh Government Arms-Length Body that facilitates health and social care innovation across Wales, connecting 200+ life sciences companies with NHS Wales, academia, and third-sector partners through funding support, sector intelligence, and coordinated programme delivery services.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Facilitation

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Management, Scientific, and Technical Consulting Services (5416)

akta.pro primary industry

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)

Keywords

• Health innovation facilitation
• Life sciences advisory services
• Programme delivery coordination
• Funding support consulting
• Sector intelligence research

Headquarters

HQ city

Cardiff

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Government Funding and Public Body Operations: Life Sciences Hub Wales is a Limited Company (Company No. 08719645) wholly owned by the Welsh Government. As an Arms-Length Body of Welsh Government, the organization operates on public funding and does not generate commercial revenue. The organization facilitates innovation in health and social care without charging for its services.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Life Sciences Hub Wales is a Welsh Government Arms-Length Body that provides innovation facilitation, advisory, and programme delivery services to accelerate life sciences innovation into frontline health and social care across Wales. Its core offering is organised around five pillars: Economic Development Support, Funding Support, Sector Intelligence, Programme Delivery, and Partnerships, supplemented by business case development, project management, and structured programmes such as the Tackling Cancer Programme. The organisation functions as a trusted connector between industry, NHS Wales, academia, and the third sector, delivering services free of charge to eligible innovators and partners.

Product overview

Life Sciences Hub Wales is an economic development and innovation support organisation — not a traditional software product company — that serves as a connector, facilitator, and driver for health and social care innovation in Wales. Rather than a single software platform, its offering is a portfolio of advisory and coordination services organised around five core pillars: Economic Development Support, Funding Support, Sector Intelligence, Programme Delivery, and Partnerships. These core services are supplemented by structured sub-products including a Business Case Development service, a Project Management Support service, and an Innovation Enquiry Form intake mechanism. Resource products include a Funding Directory, an Innovation Directory, Training & Development resources, Sector Intelligence Reports, and the Hub Highlights Newsletter. The organisation also coordinates several flagship programmes — notably the Tackling Cancer Programme, the All-Wales Robotic Assisted Surgery Programme, the QuicDNA liquid biopsy programme, the Innovation in Women's Cancer Accelerator Fund, the Health+ Programme, and the Cross-Sector Programme with the Academy of Medical Sciences — and supports specific innovations such as the Electronic Prescription Service, Virtual Reality Training for social care, and various AI-powered diagnostic tools. The overall portfolio works as an integrated support ecosystem: the directories surface opportunities and partners; the advisory services guide innovators through funding, business case, and adoption pathways; and the programmes and case studies demonstrate and accelerate real-world deployment of innovations across NHS Wales and social care.

Differentiator

Problem solved

Functional benefit

Products and services

• Economic Development Support Strategic coordination and expert navigation services to accelerate the innovation journey for health and social care innovators entering or expanding within the Welsh market, provided as a core advisory service to life sciences companies, NHS Wales organisations, and academic institutions.
• Funding Support Advisory service that helps innovators successfully identify and secure grant funding, including support for collaborative funding opportunities across health, social care, academia, and industry.
• Sector Intelligence Tailored research and market intelligence that helps innovators understand the life sciences and health and social care innovation landscape, spot opportunities, and navigate challenges within the Welsh and UK markets.
• Programme Delivery Project leadership and management expertise required to turn innovative potential into operational reality, including connecting innovators with appropriate partners across health, social care, and industry during adoption or evaluation phases.
• Partnerships Navigation services that help innovators connect with and shape high-value partnerships across NHS Wales, facilitating introductions to key stakeholders, clinical leaders, and partner organisations.
• Business Case Development Comprehensive support covering analysis and data review, development assistance, and the five-case model framework to help innovators build compelling business cases for adoption within NHS Wales and partner organisations.
• Project Management Support Project management support that connects innovators with appropriate partners across health, social care, and industry during innovation adoption or evaluation phases, providing structured delivery expertise.
• Funding Directory A searchable directory of funding opportunities for healthcare innovation, supporting collaborative projects with valuable funding information across the Welsh and UK innovation ecosystem.
• Innovation Directory A directory enabling discovery and connection with organisations actively advancing health and social care innovation across Wales, supporting networking within the Welsh innovation landscape.
• Tackling Cancer Programme A strategic initiative led by Welsh Government that leverages innovation-led partnerships to transform cancer care in Wales, coordinated by Life Sciences Hub Wales in collaboration with the Wales Cancer Industry Forum, Wales Cancer Network, and Health and Care Research Wales, delivering collaborative workshops across cancer sites to drive earlier diagnosis, treatment pathways, and improved patient experience.
• Training & Development Training resources and professional development opportunities for individuals and organisations engaged in health and social care innovation across Wales.
• Sector Intelligence Reports Research reports and intelligence publications produced by the Sector Intelligence team, providing insights into the Welsh and UK health and social care innovation landscape.
• Hub Highlights Newsletter A regular newsletter providing updates on life sciences, health and social care news, events, and innovation opportunities across Wales and beyond.
• Innovation Enquiry Form An online intake form through which innovators submit their innovation for assessment, enabling the Life Sciences Hub Wales team to understand the innovation and connect applicants with appropriate support services.
• All-Wales Robotic Assisted Surgery Programme A national programme revolutionising access to cutting-edge robotic-assisted surgery for cancer patients throughout Wales, representing a wider ambition to improve outcomes for cancer patients.
• QuicDNA A pioneering real-world study integrating liquid biopsy technologies into the healthcare system in Wales to enable faster, more personalised cancer treatment decisions through analysis of cancer DNA from blood samples. A £2.52 million investment supported expansion of ctDNA testing across Wales.
• Innovation in Women's Cancer Accelerator Fund A collaborative seed funding scheme run by the Academy of Medical Sciences and Life Sciences Hub Wales, providing up to £10,000 alongside bespoke support for UK-based organisations working on collaborative cancer innovation projects targeting women's cancers.
• Health+ Programme A digital care solutions programme through which Healthcare Matters developed Sentrix, a virtual care and smart-monitoring solution progressed towards market readiness with early interest from local authorities, care providers, and partners in Wales.
• Cross-Sector Programme (Academy of Medical Sciences Partnership) A cross-sector collaboration with the Academy of Medical Sciences bringing together healthcare professionals, industry, academia, and the third sector to foster innovation in areas including cancer, workforce, and data-driven care.

Quantifiable outcome

• 50,000 patients benefited from innovation initiatives in 2023-24
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Macmillan Cancer SupportcoreStrategic or Co-development Partner · 6 November 2025Life Sciences Hub Wales has partnered with Macmillan Cancer Support to reduce differences that exist in cancer care across Wales and help spread best practice. The partnership aims to accelerate the pace of innovation in cancer care and improve outcomes for people affected by cancer across Wales.
• Swansea UniversityminorStrategic or Co-development Partner · 28 April 2025Through the Innovation in Women's Cancer Accelerator Fund (a collaboration between Academy of Medical Sciences and Life Sciences Hub Wales), CanSense and Swansea University were announced as winners for their work on women's cancer diagnostics.
• The Telegraph and healthawareness.co.ukminorGTM or Marketing Partner · 16 December 2024Partnership as part of The Telegraph 'Future of Healthcare' campaign to showcase Wales' innovative use of artificial intelligence and big data in cancer diagnosis.
• Digital Health and Care WalescoreStrategic or Co-development Partner · 7 November 2024Life Sciences Hub Wales and Digital Health and Care Wales joined forces to drive healthcare advancements in Wales through digital innovation, combining expertise in health innovation facilitation with digital health infrastructure capabilities.
• Academy of Medical SciencescoreStrategic or Co-development PartnerOngoing partnership with the Academy of Medical Sciences through a Cross-Sector Programme that brings together innovators, researchers, and professionals from healthcare, industry, academia, and beyond. The collaboration includes joint events, funding initiatives like the Cancer Care Accelerator Fund (up to £10,000 seed funding), and Innovation in Women's Cancer Accelerator Fund.
• Welsh GovernmentcoreOthersLife Sciences Hub Wales is a Limited Company (08719645) wholly owned by the Welsh Government. As an Arms-Length Body of Welsh Government, the organization operates under government mandate to accelerate life sciences innovation across Wales, with the Tackling Cancer Initiative led by the Cabinet Secretary.
• Wales Cancer Industry ForumcoreStrategic or Co-development PartnerCollaborative forum bringing together industry partners to improve cancer services through innovation. The Forum is part of the Wales Cancer Industry Forum that provides industry leadership and strategic direction for the Tackling Cancer Programme.
• Wales Cancer NetworkcoreStrategic or Co-development PartnerKey stakeholder in the Tackling Cancer Programme, working with Life Sciences Hub Wales to coordinate cancer innovation initiatives across NHS Wales.
• Health Care and Research WalescoreStrategic or Co-development PartnerKey stakeholder collaborating with Life Sciences Hub Wales on the Tackling Cancer Programme, bringing together clinical and research expertise to advance cancer care innovation in Wales.
• NHS Wales Joint Commissioning Committee (NWJCC)coreStrategic or Co-development PartnerWorking with Life Sciences Hub Wales as part of the Welsh Government Tackling Cancer Initiative to pilot a national pathway to identify cancer treatments, technologies and approaches for prioritised adoption across Wales.
• NHS Wales Health Boards and TrustscoreStrategic or Co-development PartnerLife Sciences Hub Wales facilitates connections between industry innovators and all NHS Wales health boards and trusts, supporting innovation adoption across the entire NHS Wales ecosystem.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Regional players

• One Nucleus: Membership organisation for life sciences and healthcare companies in the Cambridge and London cluster. Comparable as a regional life sciences connector facilitating networking, partnering, and growth support, but not government-owned.
• Life Sciences Scotland: Scotland's national life sciences industry body, promoting the sector, supporting companies, and connecting industry with academia, NHS Scotland, and government. Comparable as a regional cluster organisation with similar economic-development and partnership-brokering objectives but in a separate UK nation.

Direct peers

• West Midlands Health Innovation (formerly West Midlands AHSN): Regional Health Innovation Network serving the West Midlands, supporting NHS adoption of proven innovations. Comparable in function as an NHS-aligned innovation facilitator for a defined regional health ecosystem.
• Health Innovation Network South London: One of England's 15 designated Health Innovation Networks that spreads health innovation across the NHS. Highly comparable in mandate — supporting innovators, facilitating adoption in NHS trusts, and providing sector intelligence — though operating across South London rather than Wales.
• Health Innovation West of England: Regional Health Innovation Network covering the West of England, focused on accelerating the development and adoption of health innovations. Comparable in scale and function as an NHS-aligned innovation facilitator for a defined geography.
• Health Innovation Manchester: A UK Academic Health Science Network (now Health Innovation Network) operating across Greater Manchester to accelerate the adoption of health innovation into the NHS. Directly comparable as a regional innovation facilitator with similar NHS brokering and industry-connector remit.

Broad incumbents

• NIHR (National Institute for Health and Care Research): UK's largest funder of health and care research, operating national infrastructure and programmes across England. Comparable as a public-sector body that funds and coordinates health research and innovation, though at much greater scale and with a UK-wide remit.
• Cell and Gene Therapy Catapult: UK government-backed Catapult centre focused on advancing cell and gene therapy innovation through infrastructure, partnership, and funding support. Comparable as a publicly-supported life sciences innovation accelerator, but specialised in a narrower therapy area.
• Innovate UK: UK's national innovation agency providing grant funding and growth support to innovative businesses. Comparable as a UK public-sector innovation enabler that Life Sciences Hub Wales channels funding from (e.g., £50k Growth Catalyst grant to Goggleminds).

Others

• ECHAlliance (European Connected Health Alliance): Global network connecting health innovation ecosystems across regions and countries. Comparable thematically as a connector for health innovation, but operates as a membership network rather than a government-mandated delivery body.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/lifescienceshubwales
• Facebookfacebook.com/lshubwales
• LinkedInlinkedin.com/company/lshubwales
• Instagraminstagram.com/lifesciencescymru

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Sciences Hub Wales